Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Preventive Cardiology

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1520-037X.2007.05963.XPMID 17396063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tolerability and Safety of Sustained-Release Bupropion in the Management of Smoking Cessation

  2012cited by this paper
• Clinical Efficacy of Bupropion in the Management of Smoking Cessation

  2012cited by this paper
• Rimonabant: a cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors.

  2006cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• The effect of transdermal nicotine patches on sleep and dreams.

  2006cited by this paper
• The genetics of nicotine dependence

  2006cited by this paper
• Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial

  2006cited by this paper
• Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.

  2006cited by this paper
• Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

  2006cited by this paper
• Biomarkers of exposure and potential harm in adult smokers of 3–7 mg tar yield (Federal Trade Commission) cigarettes and in adult non-smokers

  2006cited by this paper
• Nicotine enhances intracellular nicotinic receptor maturation: a novel mechanism of neural plasticity?

  2006cited by this paper
• The heart-breaking news about tobacco: it's all bad.

  2006cited by this paper
• Cytisine for smoking cessation: a literature review and a meta-analysis.

  2006cited by this paper
• Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up

  2006cited by this paper
• Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.

  2006cited by this paper
• A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.

  2005cited by this paper
• Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes.

  2005cited by this paper
• A guide to deciphering the internal codes used by the tobacco industry

  2005cited by this paper
• The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

  2005cited by this paper
• Nicotine replacement therapy and cardiovascular disease.

  2005cited by this paper
• Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

  2005cited by this paper
• The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

  2005cited by this paper
• Linking erectile dysfunction and coronary artery disease

  2005cited by this paper
• Barriers to translating emerging genetic research on smoking into clinical practice

  2005cited by this paper
• Smoking cessation in patients with coronary artery disease.

  2005cited by this paper
• Cigarette smoking among adults--United States, 2004.

  2005cited by this paper
• Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study.

  2004cited by this paper
• Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking.

  2004cited by this paper
• The influence of smoking on plasma homocysteine and cysteine levels in passive and active smokers

  2004cited by this paper
• Why people smoke

  2004cited by this paper
• Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies

  2004cited by this paper
• Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.

  2004cited by this paper
• Nicotine replacement therapy in pregnancy

  2004cited by this paper
• Antidepressants for smoking cessation.

  2004cited by this paper
• The relationship of cigarette smoking to peripheral arterial disease.

  2004cited by this paper
• Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study

  2004cited by this paper
• Smokeless tobacco and cardiovascular risk.

  2004cited by this paper
• Nicotine replacement therapy for smoking cessation.

  2004cited by this paper
• [A randomized trial of notriptyline combined with transdermal nicotine for smoking cessation].

  2004cited by this paper
• Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery.

  2004cited by this paper
• Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial

  2004cited by this paper
• The endocannabinoid system and its therapeutic exploitation

  2004cited by this paper
• Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes.

  2003cited by this paper
• Bupropion sustained release for treatment of tobacco dependence.

  2003cited by this paper
• Individual differences in nicotine intake per cigarette.

  2003cited by this paper
• Effectiveness of Bupropion Sustained Release for Smoking Cessation in a Health Care Setting: A Randomized Trial

  2003cited by this paper
• Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

  2003cited by this paper
• Monoamine oxidase and cigarette smoking.

  2003cited by this paper
• Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease.

  2003cited by this paper
• Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.

  2003cited by this paper
• Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States

  2003cited by this paper
• A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation.

  2003cited by this paper
• Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.

  2003cited by this paper
• Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.

  2002cited by this paper
• Benefits of smoking cessation for longevity.

  2002cited by this paper
• Neuronal Systems Underlying Behaviors Related to Nicotine Addiction: Neural Circuits and Molecular Genetics

  2002cited by this paper
• Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.

  2002cited by this paper
• Applying genetic approaches to the treatment of nicotine dependence

  2002cited by this paper
• Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine

  2002cited by this paper
• Nicotinic receptors mediate increased GABA release in brain through a tetrodotoxin-insensitive mechanism during prolonged exposure to nicotine.

  2002cited by this paper
• Efficacy of a nicotine lozenge for smoking cessation.

  2002cited by this paper
• Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus.

  2002cited by this paper
• Nicotine addiction: insights from recent animal studies

  2002cited by this paper
• Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo.

  2002cited by this paper
• The Nicotine Inhaler

  2001cited by this paper
• Risk of acute first myocardial infarction and use of nicotine patches in a general population.

  2001cited by this paper
• Acute effects of passive smoking on the coronary circulation in healthy young adults.

  2001cited by this paper
• Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction.

  2001cited by this paper
• Acute effects of cigarette smoking on platelet-dependent thrombin generation.

  2001cited by this paper
• A Question of Intent: A Great American Battle with a Deadly Industry

  2001cited by this paper
• Tobacco, the Food and Drug Administration, and Congress.

  2000cited by this paper
• New developments in smoking cessation.

  2000cited by this paper
• Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity.

  2000cited by this paper
• Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety

  2000cited by this paper
• The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study.

  2000cited by this paper
• Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction.

  2000cited by this paper
• Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial.

  2000cited by this paper
• Anxiolytics and antidepressants for smoking cessation.

  2000cited by this paper
• Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease.

  2000cited by this paper
• Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies.

  1999cited by this paper
• The effects of short-term passive smoke exposure on endothelium-dependent and independent vasodilation.

  1999cited by this paper
• Recent advances in the pharmacotherapy of smoking.

  1999cited by this paper
• A population-based twin study in women of smoking initiation and nicotine dependence

  1999cited by this paper
• Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study.

  1999cited by this paper
• A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

  1999cited by this paper
• Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗

  1999cited by this paper
• Cigarette smoking and mortality risk: twenty-five-year follow-up of the Seven Countries Study.

  1999cited by this paper
• Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society.

  1999cited by this paper
• Cigar smoking and death from coronary heart disease in a prospective study of US men.

  1999cited by this paper
• Papers

  1999cited by this paper
• Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.

  1999cited by this paper
• Common genetic vulnerability for nicotine and alcohol dependence in men.

  1999cited by this paper
• The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.

  1999cited by this paper
• Cigarette smoking prevalence, cessation and relapse

  1998cited by this paper
• Cigarette smoking increases sympathetic outflow in humans.

  1998cited by this paper
• Cigarette Smoking Increases Sympathetic Outflow in Humans

  1998cited by this paper
• Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

  1998cited by this paper
• Pharmacogenetics and ethnoracial differences in smoking.

  1998cited by this paper

• Effectiveness of Oral Bupropion and Nortriptyline as an Adjunct Treatment for Reducing the Use of Smokeless Tobacco: A Retrospective Study from a Tobacco Cessation Clinic in a Tertiary Care Hospital in Eastern India.

  2025cites this paper
• A mechanistic overview of approaches for the treatment of psychostimulant dependence

  2022cites this paper
• Nicotine Replacement Therapy and Healthy Lifestyle Psychoeducation for Smoking Reduction in Acute Psychiatric Inpatients: A Cluster-Randomized Parallel Study.

  2020cites this paper
• Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/− mice

  2020cites this paper
• Detoxification of Drug and Substance Abuse

  2020cites this paper
• Persistent attenuation of nicotine self‐administration in rats by co‐administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH‐23390 or the serotonin 5‐HT2C agonist lorcaserin

  2019cites this paper
• The treatment of cocaine use disorder

  2019cites this paper
• PREVALENCE AND DETERMINANTS OF TOBACCO SMOKING AND EFFECTIVENESS OF NRT FOR TOBACCO CESSATION AMONG COLLEGE STUDENTS IN A PRIVATE INSTITUTION

  2017cites this paper
• Compositions et procédés permettant de renoncer au tabac

  2015cites this paper
• Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.

  2015cites this paper
• Pharmacological strategies for detoxification

  2014cites this paper
• Comparison of the effectiveness of varenicline, extended-release bupropion and nicotine replacement therapy on the success and the maintenance of a smoking cessation program -

  2013cites this paper
• [Tobacco use and illicit substance use disorders: what should we have to do?].

  2013cites this paper
• Artigo Original Original Article

  2013cites this paper
• The impact of cigarette smoking on cardiovascular outcome in women

  2012cites this paper
• Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation.

  2011cites this paper
• Review: Nicotinic receptors and stages of nicotine dependence

  2010cites this paper
• Using System Dynamics tools to gain insight into intervention options related to the interaction between tobacco and tuberculosis

  2010cites this paper
• The Physiological Basis Of Drug Addiction

  2009cites this paper
• Smoking cessation during substance abuse treatment: what you need to know.

  2009influential citation
• Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents.

  2009cites this paper
• Four years' follow up at a smoking cessation clinic.

  2009cites this paper
• Casuística de quatro anos de uma consulta de apoio ao fumador

  2009cites this paper
• Smoking cessation pharmacotherapy

  2009cites this paper
• Vaccines in Development to Prevent and Treat Atherosclerotic Disease

  2008cites this paper
• Smoking: A Deadly Pleasant Habit—Is There a Way Out?

  2008cites this paper
• The use of bupropion SR in cigarette smoking cessation

  2008cites this paper
• Spontaneous Nicotine Withdrawal Potentiates the Effects of Stress in Rats

  2008cites this paper
• Smoking: a risk factor for progression of chronic kidney disease and for cardiovascular morbidity and mortality in renal patients--absence of evidence or evidence of absence?

  2008cites this paper
• Resolution of Oral Lesions After Tobacco Cessation

  2008cites this paper
• Resolution of oral lesions after tobacco cessation.

  2008cites this paper
• Update on the pharmacologic therapy for chronic obstructive pulmonary disease.

  2007cites this paper